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Genetic and clinical association studies have identi-
fied disrupted in schizophrenia 1 (DISC1) as a candi-
date risk gene for major mental illness. DISC1 is
interrupted by a balanced chr(1;11) translocation in
a Scottish family in which the translocation predis-
poses to psychiatric disorders. We investigate the
consequences of DISC1 interruption in human neural
cells using TALENs or CRISPR-Cas9 to target the
DISC1 locus. We show that disruption of DISC1
near the site of the translocation results in decreased
DISC1 protein levels because of nonsense-mediated
decay of long splice variants. This results in an
increased level of canonical Wnt signaling in neural
progenitor cells and altered expression of fate
markers such as Foxg1 and Tbr2. These gene
expression changes are rescued by antagonizing
Wnt signaling in a critical developmental window,
supporting the hypothesis that DISC1-dependent
suppression of basal Wnt signaling influences the
distribution of cell types generated during cortical
development.
INTRODUCTION
Schizophrenia and other major mental illnesses (MMIs) are
widely regarded to result from a combination of genetic suscep-
tibility and environmental insults. Clinical and genetic studies
indicate that schizophrenia and other MMIs are likely diseases
of altered circuitry resulting from disruptions in neurodevelop-
ment (Harrison, 1999; Weinberger, 1995; Williams et al., 2009).
The recent expansion of genome-wide association studies
(GWASs) has identified many interesting but generally weak ge-
netic linkages to MMI (Cross-Disorder Group of the Psychiatric
Genomics Consortium, 2013; Ripke et al., 2013; Schizophrenia
Working Group of the Psychiatric Genomics Consortium,1414 Cell Reports 12, 1414–1429, September 1, 2015 ª2015 The Au2014). There are also rare strong genetic variants that have
been associated with mental illness, including various copy
number variants (CNVs) and mutation of the gene disrupted in
schizophrenia 1 (DISC1) (Millar et al., 2000; Mitchell, 2011; Sulli-
van et al., 2012). DISC1 was initially associated with mental
illness upon the discovery that its coding sequence is interrupted
by a balanced chr(1;11) translocation in a Scottish family in
which the translocation cosegregates with schizophrenia, bipo-
lar disorder, andmajor depression (Blackwood et al., 2001;Millar
et al., 2000; St Clair et al., 1990). The diversity of phenotypes in
subjects harboring the translocation supports the hypothesis
that the translocation leads to a subtle underlying disruption in
neural development that predisposes to MMI by increasing
vulnerability to other environmental and genetic risk factors.
Although such rare variants are not likely to contribute signifi-
cantly to the incidence of sporadic disease, they offer valuable
opportunities for investigation. Here we engineered a disease-
relevant disruption of theDISC1 locus in an isogenic background
to investigate whether and how DISC1 mutation might lead to
a subtle underlying disruption in development that predisposes
to MMI.
DISC1 has been implicated in several neurodevelopmental
processes, including proliferation, synaptic maturation, neurite
outgrowth, and neuronal migration. In addition, many known
DISC1-interacting proteins have been associated indepen-
dently with neuropsychiatric diseases, further implicating this
network of proteins in the pathophysiology of mental illness
(reviewed in Brandon and Sawa, 2011). The vast majority of
studies showing functions of DISC1 in neural development
were performed in rodents. Dozens of splice variants of
DISC1 have been identified in the developing human brain
(Nakata et al., 2009), and the architecture of splice variant
expression is not identical in humans and rodents (Ma et al.,
2002; Taylor et al., 2003). The evolutionary divergence of
cerebral cortex development in humans and rodents, coupled
to differences at the DISC1 locus between species, highlights
the importance of interrogating the effects of disease-
relevant disruption of DISC1 isoforms in a model of human
neurodevelopment.thors
Here we study the consequences of DISC1 disruption in
isogenic stem cell lines generated using transcription activator-
like effector nucleases (TALENs) or clustered regularly inter-
spaced short palindromic repeats (CRISPR)-Cas9 to interrupt
DISC1 near the site of the balanced translocation or in an exon
common to all isoforms. Multiple isogenic clonal lines are
compared for each genotype, allowing careful study of the ef-
fects of genomic DISC1 interruption on gene expression and
neuronal development. We show that disease-relevant DISC1
targeting decreases DISC1 protein expression, which, in turn,
results in increased Wnt signaling in neural progenitor cells and
changes in expression of markers of cell fate. DISC1-dependent
Wnt signaling and changes in expression of cell fate markers can
be reversed by antagonizing the Wnt pathway during a critical
window in neural progenitor development. These experiments
suggest that disruption of long DISC1 isoforms results in
elevated basal Wnt signaling, which alters the identity of
neural progenitors, thereby modifying Wnt responsiveness and
neuronal identity. The data in this study identify the effects of
DISC1 disruption on human cerebral cortical development,
shedding light on the functions of DISC1 relevant to the patho-
genesis of major mental illness.
RESULTS
Genomic DISC1 Exon 8 Interruption Results in Loss of
DISC1 Expression because of Nonsense-Mediated
Decay
To investigate the effects of DISC1 interruption at the site of the
Scottish translocation, we introduced DISC1 frameshift muta-
tions into control induced pluripotent stem cells (iPSCs). Muta-
tions were introduced into exon 8 (within ten codons of the site
of the translocation) or exon 2 (intended to disrupt all known
coding isoforms) (Figure 1). Using TALENs or CRISPR-Cas9,
we generated isogenic human iPSC lines that are wild-type
(WT) or have frameshift mutations in exon 8 (monoallelic, exon
8 WT/mut or ex8wm; biallelic, exon 8 mut/mut or ex8mm) or
exon 2 (biallelic, exon 2 mut/mut or ex2mm). In the chr(1;11)
balanced translocation, splicing of DISC1 exon 8 to the next
two available exons on chr11 results in the introduction of a pre-
mature stop codon (PTC) within two or 61 codons. Exon 8 target-
ing generated indels that result in a PTC within three codons
(exon 8 ins 1 bp) or 27 codons (exon 8 del 1 bp). Similarly,
exon 2 targeting yielded biallelic indels, resulting in a PTC within
12 codons (exon 2 ins 1 bp) or 65 codons (exon 2 ins 2 bp).
Targeted cells maintained iPSC colony morphology, expressed
iPSC markers (Figure 1E; Figure S1), and maintained a euploid
karyotype (Figure S2). No predicted off-target cleavage events
were detected using RNA sequencing (Supplemental Experi-
mental Procedures). Multiple iPSC clones of each genotype
were used for the studies described here to minimize the poten-
tial effects of clonal variability (Table S1).
Genomic DISC1 interruption has been hypothesized to cause
expression of a truncated ormutant DISC1 or to decrease DISC1
expression from the mutated allele (Brandon and Sawa, 2011).
The introduction of a PTC into a coding RNA often results in
nonsense-mediated decay (NMD) if the PTC occurs prior to the
last exon-exon junction of the transcript (Silva and Roma˜o,Cell Re2009). Therefore, we hypothesized that genomicDISC1 interrup-
tion would cause the decay of PTC-containing mRNAs that
extended at least one exon past the interruption. Given the
complexity of human DISC1 splicing (Nakata et al., 2009), we
chose to analyze transcription at multiple DISC1 coding regions.
To examine the effects of genomic DISC1 interruption on
DISC1 expression, RNA was harvested from neural precursor
cells (NPCs) and differentiated neurons. Wild-type and DISC1-
targeted iPSCs were differentiated to neural fates using an
embryoid aggregate-based protocol (Muratore et al., 2014a,
2014b), which results in definitive neuroepithelium by day 17
and expression of neuronal makers after day 25. We character-
ized the expression of multiple isoforms of DISC1 by examining
the RNA expression of distinct exons. Day 40 neuronal qPCR an-
alyses revealed that the presence of a single exon 8mutant allele
did not significantly decrease DISC1 exon 2 expression but did
decrease expression of the longest DISC1 isoforms (Figures
2A and 2B). Biallelic exon 8 interruption significantly decreased
DISC1 exon 2 and long DISC1 transcripts (Figures 2A and 2B).
Surprisingly, biallelic exon 2 mutation did not reduce DISC1
expression (Figure 2A). We further investigated the levels of
various DISC1 isoforms in NPCs (day 17) and neurons (day 50)
using a custom NanoString probeset that included probes
targeting multiple DISC1 exons. The NanoString analyses
confirmed the qPCR data, where introduction of a PTC into
exon 8 decreased the expression of longer but not shorter
DISC1 transcripts on days 17 and 50 (Figure 2C). Unexpectedly,
exon 2 targeting appeared to decreaseDISC1 expression on day
17 (Figure 2C) but either did not change or increased the expres-
sion of various DISC1 isoforms on days 40–50 (Figures 2A–2C).
To investigate the effects of DISC1 interruption at the protein
level, we performed western blots of day 40 neuronal lysates
and analyzed DISC1 expression using a monoclonal antibody
generated against the C terminus of DISC1. This antibody de-
tected a single band of approximately 85 kDa, roughly corre-
sponding to the predicted molecular weight of translated long
(or ‘‘full-length’’) DISC1 isoforms (L, 854 amino acids [aa]; Lv,
832 aa). Single allelic DISC1 exon 8 mutation resulted in an
55% decrease in DISC1 protein expression, whereas biallelic
exon 8 mutation led to total loss of detectable DISC1 protein
(Figures 2D–2F). Biallelic exon 2 targeting showed a total loss
of full-length protein but, unexpectedly, led to the expression
of a shorter, novel DISC1 protein product in day 40 neural cells
(Figure 2D, red arrows). This truncated protein was expressed
at levels nearly identical to that of wild-type, long-isoform
DISC1 (Figure 2F). Although unexpected, the truncated DISC1
protein resulting from exon 2 mutation provided an opportunity
to analyze the effects of an independentDISC1mutation in a sys-
tem that was isogenic to our disease-relevant (exon 8 disruption)
model. Because several prior studies have demonstrated that
misexpression of a mutant-truncated DISC1 can phenocopy
DISC1 knockdown (reviewed in Brandon and Sawa, 2011), we
used our exon 2- and exon 8-targeted cells to explore whether
these observations would hold true in a human neuronal context.
To determine whether the observed changes inDISC1 expres-
sion in the disease-relevant exon 8-targeted cells were due
to NMD of PTC-containing mRNAs, we treated day 40 neurons
with cycloheximide (CHX), which inhibits NMD by interferingports 12, 1414–1429, September 1, 2015 ª2015 The Authors 1415
Figure 1. Genome Editing of the Human DISC1 Locus
(A) Diagram of the coding sequence of DISC1, with the sites of induced frameshifts and the Scottish chr(1;11) translocation indicated.
(B) Diagram of the DISC1 genomic locus, with exons shown on the top line and sample transcripts shown below. A selection of alternatively spliced isoforms is
shown in red.
(C and D) Wild-type andmutant sequences around the exon 8 (C) or exon 2 (D) targeting sites, obtained by Sanger sequencing of targeted iPS colonies. Mutation
sites are indicated with black arrowheads.
(E) Immunostaining for the pluripotent cell markers Nanog, Oct4, SSEA4, Sox2, and TRA-1-60 following genome editing. Scale bar, 50 mm.
See also Figure S1.with the ‘‘pioneer’’ round of translation required to detect the
PTC (Ishigaki et al., 2001). Analysis of DISC1 expression after
CHX treatment revealed significantly increased NMD in exon 8-
but not exon 2-targeted cells (Figures 2G and 2H). These data
suggest that introduction of a PTC into DISC1 exon 8, but not
exon 2, results in NMD of PTC-containing transcripts.
We further explored the effects of DISC1 genomic disruption
on DISC1 protein stability using CHX to prevent translation in1416 Cell Reports 12, 1414–1429, September 1, 2015 ª2015 The Auday 40 neurons. DISC1 protein was remarkably refractory to
turnover under these conditions, showing very little or no degra-
dation over 24 hr and no significant alteration in protein stability
with exon 8 or exon 2 mutations (Figure S3). The efficacy of the
CHX treatment was confirmed by detecting APP levels, which
showed a half-life of4 hr for this protein, in agreement with pre-
vious reports (Lefort et al., 2012; Vieira et al., 2010). These results
suggest that DISC1 exon 8 mutation results in NMD of longerthors
Figure 2. DISC1 Exon 8 Disruption Causes Loss of Full-Length DISC1 Expression via NMD
(A and B)Wild-type and DISC1-disrupted iPSCs were differentiated to day 40 neural fates, and RNAwas harvested for qRT-PCR ofDISC1 exon 2 (A) or exons 12/
13 (B). Expression is normalized to GAPDH and WT/WT levels. AU, arbitrary unit.
(C) iPSCs were differentiated to NPCs (day 17) and neurons (day 50), and RNA was harvested for NanoString. DISC1 probe expression was normalized to
expression of eight housekeeping genes and average WT/WT day 17 levels. Statistics are shown versus the WT of the corresponding differentiation day.
(D) Representative western blot of DISC1 in day 40 neuronal lysates. Full-length DISC1 is indicated with blue arrows. Novel truncated DISC1 is indicated by red
arrows. The red asterisks denote a nonspecific band.
(E and F) Quantification of full-length (E) or all (F) DISC1 from western blots of day 40 neuronal lysates, normalized to GAPDH and WT/WT levels.
(G and H) Day 40 neurons were treated with 100 mg/ml CHX or vehicle (DMSO) for 3 hr, followed by RNA harvest and qRT-PCR for exon 2 (G) or the exon 12/13
junction (H) of DISC1. Expression was normalized to GAPDH and average DMSO expression within the genotype.
All data were derived from at least five independent differentiations, and n is shown for each panel within bars or in the legend. Statistics: two-way ANOVA (C) and
one-way ANOVA (A, B, and E–H); mean ± SEM is shown; ns, not significant; *p < 0.05 **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S3.DISC1 transcripts and that exon 2mutation causes expression of
an N-terminally truncated DISC1 but that neither mutation desta-
bilizes DISC1 protein.
Genomic DISC1 Interruption Alters the Expression of
NPC Fate Markers
To examine the broader effects of DISC1 disruption, we charac-
terized gene expression profiles and cell fate in wild-type and
DISC1-targeted NPCs. Neural differentiation resulted in the
expression of transcription factors consistent with dorsal fore-
brain NPC fates across all genotypes on day 17 (Figure 3A). To
quantitatively measure the expression of a broad selection of
neural markers, we used a custom NanoString codeset to assay
RNA expression in rosette-selected day 17 NPCs. NanoString
analyses showed that DISC1 exon 8 and exon 2 interruptionCell Resignificantly decreased FoxG1 and Tbr2 (EOMES) expression
(Figure 3B). There was also decreased Sox1 and increased
Pax6 expression in exon 2-targeted NPCs, suggesting that
exon 2 mutation causes more dramatic changes than exon 8
interruption (Figures 3B and 3C). DISC1 interruption did not alter
the expression of other broad progenitor markers, such as Sox2,
HES1, Nestin (NES), or Vimentin (VIM) (Figures 3B and 3C). The
decrease in FoxG1 and Tbr2 RNA in the absence of decreased
expression of other cortical progenitor markers argued against
a deficit in telencephalic differentiation.
To explore putative changes in the percentage of cells ex-
pressing FoxG1 and Tbr2, we quantified immunostaining in
wild-type NPCs and NPCs with our disease model mutation,
DISC1 exon 8 WT/mut. Tbr2 quantification revealed a significant
decrease in the percentage of Tbr2-expressing cells (Figure 3D),ports 12, 1414–1429, September 1, 2015 ª2015 The Authors 1417
Figure 3. DISC1 Disruption Causes Subtle Alterations in NPC Fate
(A) iPSCs were differentiated to day 17 NPCs, rosette-selected, plated for 48 hr, and immunostained for the NPC markers as shown. Scale bar, 50 mm. DAPI,
40,6-diamidino-2-phenylindole.
(B and C) iPSCs were differentiated to day 17 NPCs and rosette-selected, and RNA was harvested for NanoString. Gene expression was normalized to
expression of eight housekeeping genes and WT/WT levels.
(legend continued on next page)
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demonstrating that the decreased Tbr2 RNA expression reflects
fewer Tbr2+ cells. In contrast, although FoxG1 RNA expression
was also decreased by DISC1 disruption, immunostaining
quantification revealed that nearly 100% of NPCs expressed
FoxG1 regardless of DISC1 mutation status (Figure 3E). This in-
dicates that the FoxG1 gene expression data reflect a per-cell
decrease in expression’ rather than a decrease in the number
of FoxG1+ cells.
DISC1 Interruption Subtly Alters Neuronal Fate but Not
Neuronal Maturity
We further investigated effects of DISC1 disruption on the
expression of cell fate markers in iPSC-derived neurons. Differ-
entiation for 40 days resulted inmarker expression characteristic
of lower- and upper-layer neurons (CTIP2, Tbr1, Cux1, Brn2, and
Satb2) as well as general neuronal markers (Tau and MAP2; Fig-
ure 4A). A population of NPCs persisted in these cultures (Nestin
and Tbr2; Figure 4A). Neural cultures of all genotypes demon-
strated spontaneous action potentials by day 42 when co-
cultured with astrocytes (Figures 4B and 4C). Gene expression
was assayed in day 50 neurons by NanoString, revealing a
persistent decrease in Tbr2 and FoxG1 in DISC1-disrupted neu-
rons (Figure 4D). There were no significant expression changes
of general neuronalmarkers (Figure 4E). Exon 2mut/mut neurons
expressed lower levels of the select mature neuronal genes
VGLUT1 (SLC17A7), GRIN1, and MAP2 (Figure 4F). Exon 8
interruption did not significantly alter neuronal layer marker
expression, whereas exon 2 interruption significantly decreased
expression of the cortical neuronal markers CTIP2 (BCL11B),
FezF2, and Tbr1, with a trend for decreased expression of other
cortical markers (Satb1 and Cux1) (Figure 4F). These gene
expression changes support the day 17 NPC data, where exon
8 interruption subtly affects the expression of cell fate markers
without impairing neuronal differentiation and exon 2 interruption
causes a broader dysregulation of neurogenesis.
We further investigated neuronal maturity by assessing the
expression of presynaptic proteins. Western blot analyses re-
vealed no significant alterations in SYP or Syn I expression
with DISC1 disruption (Figures 4G–4I), in contrast to a different
clinical DISC1 mutation (exon 12 D4bp; Sachs et al., 2005),
which has been found to result in a dramatic increase in both
(Wen et al., 2014).
RNA Sequencing Supports a Shift in Gene Expression
Profiles toward Dorsal Identities in DISC1-Interrupted
NPCs and Neurons
To obtain a genome-wide view of gene expression changes, we
performed RNA sequencing (RNA-seq) on day 17 NPC samples
and day 50 neuronal samples of wild-type and DISC1-disrupted
cells. These data show that interruption at exon 8 did not alter
global gene expression as dramatically as at exon 2 (Figure 5;
Figure S4; Table S2). Examination of cell fate markers largely(D and E) NPCswere immunostained for Tbr2 (D) or FoxG1 (E) and co-stainedwith
the Cell Counter plugin in FIJI. Only Nestin-positive cells were counted. The cells w
(WT/WT) and 5,424 (ex8wm).
Data were derived from at least five independent differentiations. Statistics: two-w
shown. *p < 0.05, **p < 0.01, ****p < 0.0001.
Cell Reconfirmed and extended the NanoString findings, suggesting a
subtle shift in the expression of cell fate markers with DISC1
interruption (Figure 5), including decreased FoxG1 expression
in DISC1-disrupted NPCs (Figure 5D). To investigate potential
dorsal-ventral fate shifts, we evaluated the expression of a
subset of dorsal and ventral markers. Because the ‘‘default’’
neuronal differentiation pathway of human stem cells generates
dorsal excitatory cortical neurons (Espuny-Camacho et al.,
2013; Kim et al., 2011; Li et al., 2009), many markers character-
istic of ventral or interneuron progenitors were not expressed in
these cells (less than ten reads in ten samples, includingNKX2-1,
NKX2-2, NKX6-2, and FOXA2). Among telencephalic progenitor
markers, expression of a selection of roof plate and dorsal pro-
genitor markers was increased (Pax3, Pax7, Msx2, NeuroG2,
Dbx2, andWnt8B), and expression of ventral progenitor markers
was decreased (ASCL1,DLX1,DLX2, andGsx2), byDISC1 inter-
ruption (Figures 5A and 5B). Notably, Pax3, Pax7, NeuroG2,
Msx2, Dbx2, Wnt8B, ASCL1, DLX1/2, GSX2, FoxG1, and
Tbr2 were identified in transcriptome-wide comparisons (Table
S2). Although this RNA-seq analysis was limited by low sample
numbers, it supports a subtle dorsal shift in cell fate with
DISC1 interruption.
Gene ontology analysis identified genes involved in neural
development, mental disorders, schizophrenia, Wnt signaling,
cell adhesion, and other pathways as being altered significantly
in our exon 8 WT/mut disease model on days 17 or 50 (Figures
5G–5J). Comparison of differentially expressed genes across
genotypes and with other existing datasets also highlights prior-
ity genes for future study based on their involvement in another
model of DISC1-related mental illness (Wen et al., 2014) or in
human neural progenitor development (Johnson et al., 2015;
Figures S4E–S4G).
The observed changes in gene expression suggested that
disease-relevant DISC1 exon 8 interruption did not drastically
alter neuronal differentiation capacity or neuronal maturation
but did result in significant changes in gene expression, including
decreased FoxG1 and Tbr2 expression. FoxG1 is a marker of
telencephalic progenitors (Molyneaux et al., 2007; Shimamura
et al., 1995; Tao and Lai, 1992; Xuan et al., 1995), whereas
Tbr2 is expressed in intermediate progenitor (IP) cells of the cor-
tex (Englund et al., 2005; Hevner et al., 2006; Sessa et al., 2008).
Although FoxG1 is expressed broadly in progenitor cells of the
developing neocortex, it is particularly critical for the differentia-
tion of ventral forebrain neurons (Manuel et al., 2010; Martynoga
et al., 2005; Xuan et al., 1995) and is expressed in a high-ventral
to low-dorsal gradient in the developing forebrain (Danesin et al.,
2009).
We hypothesized thatDISC1 disruption might subtly alter neu-
ral cell fate via an established patterning pathway. The Wnt pro-
teins are a major family of patterning molecules that are present
in a dorsal-to-ventral gradient and act on neural progenitors to
create a dorsal neuronal population (Ulloa and Martı´, 2010).DAPI. The percentage of Tbr2- or FoxG1-expressing cells was calculated using
ere counted as follows: Tbr2, 3,916 (WT/WT) and 5,873 (ex8wm); FoxG1, 5,921
ay ANOVA (B and C) and two-tailed Student’s t test (D and E). Mean ± SEM is
ports 12, 1414–1429, September 1, 2015 ª2015 The Authors 1419
Figure 4. DISC1 Disruption Does Not Alter Neuronal Differentiation Capacity or Maturity but Causes Subtle Alterations in Cell Fate
(A) iPSCs were differentiated to day 40 neuronal fates and immunostained for the markers labeled. Scale bars, 50 mm.
(B and C) Day 24 cells were dissociated and plated with human astrocytes on microelectrode arrays.
(B) Examples of day 42 single unit waveforms.
(C) Example raster plots from day 47 neurons. Each row represents one electrode. Eight representative electrodes were selected from one recording of each of
the genotypes as shown.
(D–F) iPSCs were differentiated to day 50 neuronal fates, and RNA was harvested for NanoString. Gene expression was normalized to expression of eight
housekeeping genes and WT/WT levels.
(legend continued on next page)
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Artificially elevating Wnt signaling in the developing rodent cor-
tex has been shown to decrease FoxG1 expression and cause
a dorsal shift in neural identity (Backman et al., 2005). Wnts
have also been shown to trigger IP differentiation and premature
neuronal differentiation, therefore reducing the abundance of
Tbr2-positive cells in the cortex (Hirabayashi et al., 2004; Munji
et al., 2011). Finally, DISC1 has been shown to participate in
the Wnt signaling pathway via interactions with GSK3b (Mao
et al., 2009) or D2R (Su et al., 2014). Because the observed
changes in gene expression and cell fate could all be related to
reported effects of increased Wnt signaling, and because
DISC1 has been shown to have multiple roles in the Wnt
pathway, we next sought to investigate the Wnt signaling prop-
erties of DISC1-targeted neural progenitors.
DISC1-Disrupted NPCs Display Elevated Baseline Wnt
Signaling Activity Independent of Dorsal Identity
We investigatedcanonicalWnt signaling inNPCsderived fromour
isogenic wild-type and DISC1-disrupted iPSCs. We evaluated
Wnt signaling by introducing a T cell factor (TCF)/(lymphoid
enhancer factor (LEF)-responsive luciferase (Super8xTOPFLASH)
into cells by Amaxa nucleofection, followed by incubation with
control (L) or Wnt3a (W) conditioned media (CM) for 24 hr. Anal-
ysis of luciferase activity in cell lysates showed thatDISC1-disrup-
ted NPCs displayed decreased Wnt responsiveness, with a
smaller fold change in luciferase activity after Wnt3a application
relative to control NPCs (Figure 6C). However, this decreased
Wnt response is driven by increased baseline Wnt signaling in
DISC1-disrupted cells (WT versus DISC1 mutant L CM luciferase
activity; Figure 6B). Interestingly, this phenotype is not present in
iPSCs (Figure S5), highlighting the cell fate specificity of this
DISC1-mediated alteration in Wnt signaling. These results sug-
gest thatDISC1 disruption decreases theWnt response in human
telencephalic NPCs by increasing basal Wnt signaling.
We next explored the functional consequences of the
observed increase in baseline Wnt signaling with DISC1 disrup-
tion by examining NPC proliferation in wild-type andDISC1 exon
8 WT/mut cells. 5-Ethynyl-20-deoxyuridine (EdU) incorporation
showed an increase in the basal proliferation rate of exon 8
WT/mut NPCs relative to wild-type cells (Figures 6D and 6E).
These studies suggest that the increased baseline luciferase
Wnt signaling activity in DISC1-disrupted NPCs results in
increased baseline neural progenitor proliferation.
The fate-related gene expression changes and increased
baseline Wnt signaling observed in DISC1-disrupted cells could
be related or independent phenotypes. Altered cell fate could
modify Wnt signaling by changing the pool of cells being as-
sayed, increased baseline Wnt signaling could alter cell fate,
or altered Wnt signaling and cell fate could be interrelated in a
more complex manner. If dorsal NPC fates have different
intrinsic Wnt signaling properties than more ventral NPCs,(G and H) Quantification of western blots for SYP (G) and SYN I (H) in day 40 neuro
to MAP2 and GAPDH).
(I) Representative western blot of the neuronalmarkers SYN I, SYP,MAP2, and Tau
samples as those shown in Figure 2D (GAPDH is shown in both for reference).
Data were derived from at least eight independent differentiations. Statistics: tw
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Cell Rethen changes in Wnt signaling may be observed in dorsally
shifted NPCs. To assess whether the observed alteration in
Wnt signaling could be induced in wild-type cells by forcing a
dorsal fate, we pushed NPCs to more dorsal fates by antago-
nizing Shh signaling with cyclopamine during days 5–17 of dif-
ferentiation (Chen et al., 2002; Wen et al., 2014). NPCs were
rosette-selected and cultured as neural aggregates without cy-
clopamine for 13 days prior to Wnt signaling assays (Fig-
ure 6A). Cyclopamine pretreatment did not alter baseline levels
of Wnt signaling or Wnt responsiveness in wild-type or DISC1-
disrupted NPCs (Figures 6F and 6G). In parallel with Wnt
assays, dissociated NPCs were plated and differentiated as
neurons for 16 days, followed by RNA harvest. NanoString
showed that a window of prior cyclopamine exposure did not
alter the expression of many cell fate markers, supporting pre-
vious studies demonstrating the default dorsal fate of NPCs
differentiated from human pluripotent cells (Espuny-Camacho
et al., 2013; Kim et al., 2011; Li et al., 2009). Cyclopamine
treatment did decrease FoxG1 expression in wild-type cells
(Figure 6H), suggesting that decreased FoxG1 expression in
DISC1-disrupted cells can be mimicked in wild-type cells
using cyclopamine to dorsalize NPCs. However, the increased
baseline Wnt signaling and decreased Wnt-responsiveness of
DISC1-disrupted NPCs is not induced in wild-type cells with cy-
clopamine treatment. Therefore, shifting cells to a more dorsal
identity is not sufficient to induce the altered Wnt signaling
seen in DISC1-disrupted cells.
Wnt Signaling and Gene Expression Changes in DISC1-
DisruptedCells CanBeRescuedwithWnt Antagonism in
a Critical Window of Neurodevelopment
The elevation in baseline canonical Wnt signaling in DISC1-dis-
rupted NPCs suggested an alternate mechanism whereby
DISC1 interruption alters cell fate via increased Wnt signaling.
To test this hypothesis, we treated wild-type and DISC1 exon
8 WT/mut NPCs with either a Wnt agonist (CHIR99021 [CHIR])
or antagonist (XAV939 [XAV]) during days 7–17 of differentiation.
Immunostaining of NPCs showed dramatic morphological and
gene expression changes with CHIR99021 treatment, including
decreased FoxG1 and Tbr2 expression and increased MAP2
expression, whereas XAV treatment had no qualitative effects
on immunostaining of neural markers (Figure 7A). Neural rosettes
were then cultured in suspension as neural aggregates in the
absence of small molecules prior to assayingWnt signaling. Prior
Wnt agonism causedwild-type cells tomimic the decreasedWnt
responsiveness of DISC1-targeted cells (Figure 7C). CHIR99021
treatment also caused a dramatic decrease in Wnt baseline
signaling, likely because of the observed decrease in NPCs
and increase in premature neuronal differentiation (Figures 7A
and 7B). In contrast, prior Wnt antagonism with XAV939
decreased baseline Wnt signaling and increased Wntnal lysates, normalized to Tau (similar results were observed with normalization
and the loading control GAPDH in day 40 neuronal lysates. These are the same
o-way ANOVA (D–F) and one-way ANOVA (G and H). Mean ± SEM is shown.
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Figure 5. RNA-Seq Supports a Dorsal Fate Shift in DISC1-Targeted NPCs and Neurons
iPSCs were differentiated to NPCs (day 17) and neurons (day 50), and RNA was harvested for RNA-seq. Counts were upper quartile-normalized.
(A–F) Expression of selected (A) dorsal telencephalic markers, (B) ventral telencephalic markers, (C and D) NPC markers, and (E and F) neuronal markers.
Statistics are shown versus the WT of the corresponding differentiation day. Data were derived from two to six independent differentiations. Statistics: two-way
ANOVA. Mean ± SEM is shown. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
(G–J) Gene ontology analysis of exon 8 WT/mut versus WT/WT day 17 (G and H) and day 50 (I and J) cells.
See also Figure S4.responsiveness in DISC1 exon 8 WT/mut NPCs (Figures 7B and
7C). The altered Wnt response of DISC1-targeted NPCs can
therefore be rescued by prior Wnt antagonism during a 10-day
window early in neural development.1422 Cell Reports 12, 1414–1429, September 1, 2015 ª2015 The AuConcurrent with Wnt signaling assays, NPCs were plated and
differentiated as neurons for 16 days, followed by RNA harvest
and gene expression analyses. Antagonizing NPC Wnt signaling
with XAV939 rescued decreased FoxG1, Brn2, and Tbr2thors
Figure 6. DISC1 Interruption Increases
Basal Wnt Signaling and Decreases Wnt
Responsiveness in NPCs Independent of
Shh Antagonism
(A) Schematic of the experimental design.
iPSC-derived day 24NPCswere nucleofected with
plasmids encoding the Super8XTOPFlash lucif-
erase reporter and pMIR-REPORT-b-galactosi-
dase as a marker of transfection efficiency. After
18 hr, media were changed to control (L) or Wnt3a
(W) CMs for 24 hr, followed by cell lysis. IGF,
insulin-like growth factor; BDNF, brain-derived
neurotrophic factor; GDNF, glial cell-derived neu-
rotrophic factor; NE, neuroepithelium.
(B–E) Cell lysate luciferase activity was normalized
to b-galactosidase activity andWT/WT L levels (B),
L levels within genotype (C), WT/WT DMSO L
levels (D), or L levels within condition (E).
(B and C) DISC1 disruption causes increased
baseline Wnt signaling (B), which drives the
decreased Wnt response (C).
(D and E) DISC1 interruption increases baseline
NPC proliferation. NPCs were cultured in control
CM for 24 hr, followed by addition of 10 mMEdU for
4 hr and EdU withdrawal for 4 hr.
(D) Example images of EdU and DAPI.
(E) Quantification of percent EdU/DAPI. Data were
derived from four independent differentiations.
(F and G) Wild-type and DISC1-disrupted cells
treated with vehicle (DMSO) or cyclopamine
(cyclop) to dorsalize NPCs for days 5–17 do not
alter baselineWnt signaling (F) or theWnt response
(G). Statistics in (F) are shown versus WT DMSO L.
Statistics in (G) are shown versus WT DMSO W.
Sample numbers are shown in the columns.
(H) RNA was harvested from day 40 neurons
and used for NanoString. Gene expression was
normalized to all genes. Statistics are shown
versus WT DMSO.
Mean ± SEM is shown. Data were derived from at
least three independent differentiations. Statistics:
one-way ANOVA (B–G) and two-way ANOVA (H).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Figure 7. Wnt Antagonism in a Critical Early Window Rescues Altered Wnt Signaling and Cell Fate in DISC1-Disrupted Cells
iPSCs were differentiated to NPCs and treated with vehicle (DMSO), the Wnt antagonist XAV939, or the Wnt agonist CHIR during days 7–17. After rosette
selection on day 17, small molecules were withdrawn.
(A) Examples of immunostained NPCs (day 19) are shown. Scale bar, 50 um.
(B and C) Prior exposure to Wnt, the antagonist XAV939 decreases baseline Wnt signaling and increases Wnt responsiveness in NPCs, whereas the Wnt agonist
CHIR99021 decreases Wnt responsiveness. iPSC-derived NPCs were nucleofected with plasmids encoding the Super8XTOPFlash luciferase reporter and
(legend continued on next page)
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expression in exon 8 WT/mut neurons (Figures 7D and 7E).
XAV939 also rescued increased DAB2 expression in exon 8
WT/mut cells, whereas CHIR99021 increased DAB2 levels in
WT and exon 8 WT/mut neurons (Figure 7F).
Stimulating Wnt signaling with CHIR99021 pushed NPCs
to differentiate spontaneously, decreasing the expression of pro-
genitor markers and cortical layer markers (Figures 7D and 7E).
CHIR99021 treatment also resulted in decreased expression of
the ventral markerGSX2 and increased expression of the caudal
genes HOXA1/2 and HOXB4, consistent with the effects of Wnt
in dorsal and posterior patterning (Figure 7E). Furthermore, prior
treatment of NPCs with CHIR99021 altered neuronal expression
of the Wnt pathway genes AXIN2, Irx3, and Six3 (Figure 7F). The
reversal of gene expression changes in exon 8-targeted neurons
with Wnt antagonism during NPC development suggests that
altered cell identity in DISC1-disrupted cells is downstream of
increased Wnt signaling. Wnt antagonism in DISC1 exon 8 WT/
mut cells also rescued increased baseline Wnt signaling and
decreased Wnt responsiveness in DISC1-targeted NPCs. These
studies support a model in which altered Wnt signaling and cell
identity are interdependent phenotypes in DISC1-disrupted
NPCs and neurons (Figure S6).
DISCUSSION
The study of genetic predispositions to mental illness, even if
found only in a small subset of patients, will improve our under-
standing of the pathophysiology of these debilitating disorders.
Both rare, highly penetrant and common, weakerDISC1 variants
have been associated with multiple MMIs (reviewed in Brandon
and Sawa, 2011). The Scottish chr(1;11) translocation provides
an opportunity to investigate the pathophysiology of a rare ge-
netic alteration that has been strongly linked to MMI (Porteous
et al., 2014). Animal models have identified critical neurodeve-
lopmental roles for DISC1 (Brandon and Sawa, 2011). Because
of differences in DISC1 splicing between human and rodent
samples (Ma et al., 2002; Nakata et al., 2009) as well as the
evolutionary divergence in the development of the cerebral cor-
tex, there is a need to complement animal models with studies of
human neurons and glia. Furthermore, although DISC1 has been
shown to function in a myriad of pathways, studies such as ours
prioritize the developmental phenotypes relevant to increasing
risk for MMIs.
It is important to keep in mind that patients with MMI, with or
without DISC1 disruption, do not show dramatic morphological
alterations in the brain and do not show global neuronal dysfunc-
tion. To identify relatively subtle developmental defects and to
attribute these to a particular mutation, it may be necessary topMIR-REPORT-b-galactosidase as amarker of transfection efficiency. After 18 hr
lysis. Cell lysate luciferase activity (luc) was normalized to b-galactosidase activity
(C). Sample numbers are shown in the columns.
(D–F) RNA was harvested from day 40 neurons and used for NanoString.
(D and E) Expression of selected progenitor and neuronal, dorsal, ventral, and ca
(F) Expression of Wnt pathway genes.
Gene expression was normalized to all genes. Significance asterisks in dark blue
All luciferase assay and NanoString samples were independent of samples use
independent differentiations. Statistics: one-way ANOVA (B and C) and two-way
Cell Regenerate isogenic lines and interrogate multiple lines over
several differentiations with high numbers of wells. To investigate
the consequences ofDISC1 interruption in human neuronswith a
controlled genetic background, we TALEN- and CRISPR-Cas9-
targeted iPSCs. We found that genomic DISC1 interruption near
the site of the Scottish chr(1;11) translocation causes loss of
expression of longer DISC1 transcripts from the mutated allele
by NMD, which increases baseline Wnt signaling and alters the
transcriptional profile of NPCs and neurons. These data support
a loss-of-function model in which DISC1 interruption causes
decreased full-length DISC1 expression and has downstream
developmental consequences.
The limited evidence that exists from t(1;11) patients suggests
that the translocation lowers DISC1 transcript and protein levels
in patient-derived non-neuronal cells (Millar et al., 2005). Based
on the genomic structure surrounding the t(1;11) breakpoint, if
splicing occurs between DISC1 exon 8 and the next available
exon on chr11, then the resulting transcript would contain a
PTC prior to the last exon of the chr11 gene. This fusion tran-
script should therefore also recruit the NMD pathway, as
observed in our exon 8 mutant model. The common effect of
exon 8 1-bp insertion or deletion on decreasing DISC1 expres-
sion suggests that the number of codons (3 or 27) preceding
the PTC does not alter targeting of the transcript for NMD. The
exon 2 mutant lines demonstrate that an independent DISC1
mutation can dysregulate many of the same processes as our
disease-relevant exon 8 disruption and has even stronger ef-
fects on neuronal cell identity. The phenotypes observed in
exon 2 lines may result from a loss of long DISC1 isoforms
and/or expression of the truncated protein. Because exon 2 mu-
tation does not dramatically alter DISC1 transcript structure by
RNA-seq (Figure S4A), we hypothesize that the truncated
DISC1 protein may result from forced use of an alternate start
codon downstream of the introduced frameshift mutation. It
should be noted that, because we have not generated the
chr(1;11) translocation, we could not assess for the presence
of a fusion transcript, evaluate the effects of disruption of the
antisense long non-coding RNA (lncRNA) DISC2, or assess for
alterations in expression of translocation-adjacent genes. In pa-
tients carrying t(1;11), there has been no evidence of expression
of a truncated DISC1 or a DISC1 fusion protein with the nearest
downstream chromosome 11 gene (DISC1FP1 or Boymaw)
(Millar et al., 2005). However, there is evidence of expression
of a fusion protein of DISC1 with the upstream gene, translin-
associated factor X (TSNAX/TRAX), in the brain (Millar et al.,
2000). The balanced translocation may affect expression of
this protein in a manner that is not recapitulated with our engi-
neered mutations., media were changed to control (L) or Wnt3a (W) CMs for 24 hr, followed by cell
(b-gal) andWT/WT DMSO L levels (B) or L levels within the treatment condition
udal markers.
are versus WT/WT DMSO, and asterisks in light blue are versus ex8wm DMSO.
d in Figure 6. Mean ± SEM is shown. Data were derived from at least three
ANOVA (D–F). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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The results described here reveal a role of DISC1 disruption
in disordered neurodevelopment. Previous analyses of sporadic
psychiatric disease with human iPSCs have also shown
changes in neural development (Brennand et al., 2011, 2015;
Yu et al., 2014). Another study used iPSCs with a distinct
DISC1 mutation found in an American family in which a 4-bp
deletion in exon 12 co-segregates with schizophrenia (Sachs
et al., 2005; Wen et al., 2014). Although the causality of this mu-
tation remains unclear based on pedigree size and identification
of the mutation in control subjects (Green et al., 2006), this mu-
tation resulted in dysregulation of presynaptic biology, including
increased presynaptic protein expression in cortical neurons
(Wen et al., 2014). We did not observe an upregulation of pre-
synaptic proteins with exon 8 or exon 2 DISC1 interruption.
The differentiation methods used in that study included the
use of dual SMAD inhibition and cyclopamine, which likely gen-
erates a different population of neural progenitors and neurons,
which, in turn, may alter the resulting neuronal phenotypes (He´-
bert and Fishell, 2008). Interestingly, although the phenotypes
described are divergent between our studies, a common subset
of genes is dysregulated with the two models (Figure S4F).
Future studies with these models have the potential to provide
a powerful system to identify convergent phenotypes of these
disparate DISC1 mutations.
Here we found that disease-relevant DISC1 disruption alters
canonical Wnt signaling in human NPCs, as assessed by TCF/
LEF-driven gene expression. We observed that DISC1 disrup-
tion decreases Wnt responsiveness in human NPCs, consistent
with the decreased Wnt response upon DISC1 knockdown in
murine NPCs (Mao et al., 2009). That study suggested a direct
role for DISC1 in the Wnt signaling pathway, in which DISC1
binds and inhibits GSK3b. Here we find that that the loss of
long DISC1 isoforms drives decreased Wnt responsiveness via
elevated baseline Wnt signaling. This difference may result
from the use of human versus rodent cells or the use of total
DISC1 knockdown versus disease-relevant loss of long DISC1
transcripts or may suggest a different role for DISC1 in the Wnt
signaling pathway.
The Wnt signaling pathway has been implicated in the patho-
physiology of neuropsychiatric disorders, making the role of
DISC1 in this pathway of particular interest (Freyberg et al.,
2010). We found that DISC1 disruption causes altered NPC
and neuronal gene expression profiles via increased Wnt
signaling. Our data are consistent with rodent models in which
increased Wnt signaling in the developing brain causes a dorsal
NPC fate shift, decreases FoxG1 expression, and decreases
Tbr2 expression by promoting IP differentiation (Backman
et al., 2005; Munji et al., 2011). Wnt inhibition with XAV939 for
a 10-day window in DISC1-targeted NPCs rescued changes in
neural cell identity, suggesting that increased Wnt signaling
with DISC1-disruption is upstream of observed gene expression
differences. The increase in Tbr2 expression with XAV939
treatment upholds, and extends to human telencephalic cells,
previous reports that Wnt antagonism causes an expansion of
Tbr2+ IPs (Fang et al., 2013, 2014; Munji et al., 2011). These
studies suggest a model in which DISC1 interruption increases
baseline Wnt signaling, which alters the pool of NPCs, resulting
in decreased Wnt responsiveness.1426 Cell Reports 12, 1414–1429, September 1, 2015 ª2015 The AuFurther work will be required to elucidate the exact mecha-
nism by which DISC1 disruption alters Wnt signaling and
fate-related gene expression profiles in human NPCs. We iden-
tified numerous gene expression changes that result from
DISC1 interruption by RNA sequencing, which provide inter-
esting candidates for future study. This study shows the utility
of human iPSCs in modeling mental illness-associated defects
in human neurodevelopment and strengthens the association
between Wnt signaling, neurodevelopment, and major mental
illness.
EXPERIMENTAL PROCEDURES
Genome Editing
The healthy control human iPSC line YZ1 was obtained from the University of
Connecticut Stem Cell Core (Zeng et al., 2010). TALENs were designed and
constructed using a hierarchical ligation procedure (Sanjana et al., 2012).
TALE monomer plasmids and TALEN backbone plasmids were a generous
gift from Feng Zhang. Exon 8 TALENs were designed targeting unique
genomic sequences in DISC1 exon 8. For CRISPR-Cas9 targeting, a unique
genomic site in DISC1 exon 2 was cloned into a guide RNA cloning vector.
Targeting plasmids were electroporated into dissociated YZ1 iPSCs
using the Amaxa 4D-Nucleofector X unit (Lonza). 48 hr after transfection,
iPSCs were dissociated, and GFP+ cells were collected by fluorescence-
activated cell sorting (FACS). Individual clones were screened for genomic
mutation by PCR amplification around the target site, followed by Sanger
sequencing.
Neuronal Differentiation
Neuronal differentiation was performed using an embryoid aggregate-based
protocol, as described previously (Muratore et al., 2014a, 2014b). For dor-
sal-ventral patterning, cells were treated with 2 mM cyclopamine (Santa Cruz
Biotechnology) or vehicle (DMSO, Sigma) as indicated during days 5–17 of dif-
ferentiation. For Wnt manipulation, cells were treated with 2 mM XAV939
(Stemgent), 3 mM CHIR99021 (Tocris Bioscience), or vehicle (DMSO), as indi-
cated, during days 7–17 of differentiation. See Supplemental Experimental
Procedures for details and media recipes.
qPCR
RNA was reverse-transcribed, and cDNA was used for qPCR with Fast SYBR
Green Master Mix (Life Technologies) on a ViiA 7 system (Life Technologies).
Data were normalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) expression using the DDCT method as described previously (Livak
and Schmittgen, 2001). Primer sequences are listed in the Supplemental
Experimental Procedures.
NanoString Gene Expression Analysis
Two 150-gene nCounter Custom CodeSets were designed by NanoString
Technologies. One codeset was used to generate initial expression data
(Figures 2, 3, and 4; Table S3A). Data were analyzed by subtracting counts
from a blank control and normalizing to eight housekeeping genes
(B2M, GAPDH, GUSB, HPRT1, LDHA, POLR2A, RPL13a, and RPL27). After
this codeset was depleted, another codeset was made that greatly overlap-
ped with the initial codeset. This codeset was used to generate patterning
data (Figures 6 and 7; Table S3B). These data were analyzed with nSolver
analysis software (NanoString Technologies) and normalized to the
total gene set. Assays were performed according to the manufacturer’s
instructions.
Immunocytochemistry and Microscopy
Cells were fixed with 4% paraformaldehyde (Sigma), followed by membrane
permeabilization and blocking with 0.2% Triton X-100 (Sigma) and 2%
donkey serum (Jackson ImmunoResearch Laboratories). All quantifications
were performed blinded to genotype using the Cell Counter plugin inthors
FIJI. See the Supplemental Experimental Procedures for a list of antibodies
used.
Western Blots
Lysates were prepared in a buffer containing 1%NP40, 10mMEDTA, 150mM
NaCl, 50mMTris, complete protease inhibitors, and phosSTOP (Roche). Equal
protein amounts were loaded onto 4%–12% Bis-Tris NuPAGE gels (Life Tech-
nologies) and transferred to nitrocellulose membranes for blotting. Antibodies
and dilutions are listed in the Supplemental Experimental Procedures.
RNA Sequencing
RNA was extracted from day 17 or day 50 samples. Total RNA was converted
into cDNA libraries using the TruSeq Stranded Total RNA-RiboZero Gold sam-
ple prep kit (Illumina). RNA was sequenced on an Illumina HiSeq using
stranded paired-end reads with 50 million reads/sample.
Differential Gene Expression Analysis
Reads were mapped to the University of California, Santa Cruz human refer-
ence genome (hg19) using TopHat v2.0.10 (Kim et al., 2013). Reads mapping
to genes were counted using htseq (v0.6.1) (Anders et al., 2015). Counts were
upper quartile-normalized using SVS (Golden Helix) for limited gene compari-
sons. Alternatively, differential gene expression analysis between lines was
performed using the edgeR package in R with a false discovery rate of 0.05
(Robinson et al., 2010).
Luciferase Assays
Control and Wnt3a CMs were produced using Wnt3a-expressing and control
(L) cells (ATCC). CMs were generated according to the ATCC protocol. Neural
aggregates (days 27–31) were dissociated using Accutase. Cells were
electroporated with Super8XTOPFlash (a gift from Randall Moon) and pMIR-
REPORT-b-galactosidase (Life Technologies) using the Amaxa 4D-Nucleofec-
tor X unit (Lonza). 16 hr later, the medium was changed to L or Wnt3a CM for
24 hr. Cells were then lysed and used for a firefly luciferase assay (Biotium) and
b-galactosidase assay (Promega). Luciferase activity was normalized to
b-galactosidase activity for each sample.
EdU Incorporation
Neural aggregates (days 27–31) were dissociated using Accutase and plated
onto poly-ornithine/laminin-coated 96-well plates at 25,000 cells/well. 16 hr
later, the medium was changed to L CM for 24 hr. Cells were then incubated
in L CM + 10 mM EdU for 4 hr, followed by incubation in L CM (without EdU)
for 4 hr. Cells were then fixed as described above, and EdU staining was
carried out using a Click-iT EdU imaging kit (Invitrogen).
To quantify the EdU signal, cells were imaged using an IN Cell Analyzer 2000
high-content platform (GE Healthcare). Image sets were analyzed using
the multi-target analysis algorithm in the IN Cell Workstation software (GE
Healthcare).
Data Collection and Statistics
All data represent at least three independent experiments, with the minimum
‘‘n’’ and number of differentiations listed in each figure or figure legend, and uti-
lizing the iPSC lines as shown in Table S1. Data were analyzed usingGraphPad
PRISM 6 software. Values are expressed as mean ± SEM. Statistical signifi-
cance was tested as indicated in the figure legends.ACCESSION NUMBERS
The accession number for the data reported in this paper is GEO: GSE71289.SUPPLEMENTAL INFORMATION
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